GENEVA, Sept. 7 -- HANGZHOU JIAYIN BIOTECH LTD. filed a patent application (CN2025/129348) for “A NOVEL INTRAVITREAL GENE THERAPY FOR NEOVASCULAR DISEASES”. With publication no. WO/2026/086836, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: C12N 15/864
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....